Delivery Order SPE2DB22D2206-SPE2DB25FJC63
- Not listed
- The Defense Logistics Agency awarded a $2,682.39 delivery order to AmerisourceBergen Drug Corp for Exforge 10-320 mg tablets (30 count) on July 21, 2025, with completion scheduled for July 22, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a $16,889.00 delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Exforge 10-320 mg, a combination antihypertensive medication. This competitively awarded, firm fixed-price contract was executed on July 23, 2025, with an ultimate completion date of July 24, 2025, and represents a child delivery order under a larger indefinite delivery contract vehicle. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,992.17 to AmerisourceBergen Drug Corp for Exforge 10-160 mg tablets (30-count supply) on July 21, 2025, with completion scheduled for July 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Exforge HCT 10-160-12.5 mg tablets (30-count bottles) with a ceiling value of $3,049.40. This competitively awarded, firm fixed-price delivery order was issued on July 24, 2025, with an ultimate completion date of July 25, 2025. The contract utilizes no set-aside designation and identifies Conshohocken, Pennsylvania as the place of performance, which is also the location of...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract worth $3,419.41 by the Defense Logistics Agency (DLA) to provide EXFORGE 5-160 MG TABLET 30S, a pharmaceutical product, with a completion date of January 26, 2024. This award is part of Amerisourcebergen Drug Corp's broader role as the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through...
- The Defense Logistics Agency (DLA) awarded a $1,076.29 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide EXFORGE HCT 10-160-12.5 MG TAB 30S. This is a component of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,743.68 firm fixed-price contract is for the delivery of EXFORGE 5-160 MG TABLET 30S, a cardiovascular medication, to support military healthcare programs. The contract has an ultimate completion date of September 20, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,707.67, is for the delivery of Exforge 10-320 mg tablets over a period ending on April 15, 2025. This appears to be a Firm Fixed Price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,438.83 firm fixed-price delivery order is for the supply of EXFORGE 10-320 MG TABLET 30S, a medical product, with a completion date of January 8, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $1,685 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 30 tablets of Exforge 10-160 mg to a location in Conshohocken, Pennsylvania, with performance required from August 15 through August 16, 2023. As a leading provider of pharmaceuticals and healthcare solutions to the Department of Defense, Amerisourcebergen will deliver the specified medication in support of...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJC63Delivery Order
The Defense Logistics Agency awarded a $1,679.83 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Exforge 5-320 mg tablets (30-count). This firm fixed-price contract, with an ultimate completion date of July 29, 2025, represents a non-competitive set-aside delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate headquarters in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its primary operations as a major healthcare distributor serving federal procurement needs. AmerisourceBergen Drug Corp holds a significant prime IDC valued at $999,999,999.00 through December 2026 designated as SPE2DX, which serves as the overarching contract vehicle enabling the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. This delivery order for Exforge, an antihypertensive combination medication, exemplifies the routine pharmaceutical procurement executed under this global pharmaceutical support vehicle. The award reflects AmerisourceBergen's continued role as a critical vendor for the Defense Logistics Agency's medical supply chain, supporting Defense Health Agency operations and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 7/28/25 |